These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37350808)

  • 1. Comprehensive Analysis Reveals the Potential Roles of Transcription Factor Dp-1 in Lung Adenocarcinoma.
    Song Y; Ma R
    World J Oncol; 2023 Jun; 14(3):205-223. PubMed ID: 37350808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
    Fan K; Zhang BH; Han D; Sun YC
    BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F7 serves as a potential prognostic biomarker for lung adenocarcinoma.
    Lin S; Yu X; Yan H; Xu Y; Ma K; Wang X; Liu Y; Xie A; Yu Z
    Medicine (Baltimore); 2024 Jan; 103(3):e34342. PubMed ID: 38241554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
    Wei Q; Miao T; Zhang P; Jiang B; Yan H
    Front Genet; 2022; 13():984575. PubMed ID: 36159963
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-SMC condensin I complex subunit H (NCAPH), a regulator of cell cycle, predicts poor prognosis in lung adenocarcinoma patients: a study mainly based on TCGA and GEO database.
    Zhou W; Hu J; Zhao J
    Transl Cancer Res; 2020 Dec; 9(12):7572-7587. PubMed ID: 35117357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma.
    Guo W; Huai Q; Zhang G; Guo L; Song P; Xue X; Tan F; Xue Q; Gao S; He J
    Front Oncol; 2020; 10():598437. PubMed ID: 33569346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-cancer Analysis of the Disulfidptosis-related Gene NCKAP1 and Its Prognostic Value for Lung Adenocarcinoma.
    Zhu A; Zong Y; Wei S; Li Y; Fan Y; Liu S; Gao X
    J Cancer; 2023; 14(17):3351-3367. PubMed ID: 37928421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
    Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
    Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of the prognostic values and immune implication of ESYT3 in lung adenocarcinoma.
    Li X; Chen J; Meng J
    Medicine (Baltimore); 2023 Sep; 102(35):e34557. PubMed ID: 37657044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of LncRNA-UCA1 Correlates with Lung Adenocarcinoma Progression and Poor Prognosis.
    Chen L; Cao P; Wu Q; Guo Y; Yang Y; Chen F
    Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.
    Cao K; Ling X; Jiang X; Ma J; Zhu J
    Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative Multi-Omics Analysis of Identified SKA3 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma.
    Lin Y; An J; Zhuo X; Qiu Y; Xie W; Yao W; Yin D; Wu L; Lei D; Li C; Xie Y; Hu A; Li S
    Int J Gen Med; 2022; 15():4635-4647. PubMed ID: 35535142
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX
    Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic analysis of the prognostic and immunological role of DHX33 in pan-cancer.
    Ding J; Zhou J; Shen X; Zhang M; Feng X; Xu Z
    Environ Toxicol; 2023 Aug; 38(8):2011-2021. PubMed ID: 37256545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis.
    Liu TT; Li R; Huo C; Li JP; Yao J; Ji XL; Qu YQ
    Front Cell Dev Biol; 2021; 9():682002. PubMed ID: 34409029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma.
    Yang Y; Hu Z; Sun H; Yu Q; Yang L; Yin F; Sun Y; Pu L; Zhu X; Li S; Chen X; Zhao Y
    Onco Targets Ther; 2021; 14():5477-5492. PubMed ID: 34992383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma.
    Yang B; Ji LL; Xu HL; Li XP; Zhou HG; Xiao T; Li XH; Gao ZY; Li JZ; Zhang WD; Wang GS; Li MJ
    J Inflamm Res; 2021; 14():2389-2401. PubMed ID: 34163207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.